Oyogist.com has learnt that the European Union’s drug regulatory agency denied claims of increase in blood clotting linked with the Oxford AstraZeneca Covid-19 vaccine.
The reports from the European Medicines Agency could lead to a possible lift in the suspension of the vaccine by serveral European countries.
According to the head of the European Medicines Agency, Emer Cooke, the agency “cannot rule out definitively a link” between rare types of blood clots and the vaccine, however, and experts recommend raising awareness among doctors and recipients of possible risks”.
“Our scientific position is that is that this vaccine is a safe and effective option to protect citizens against COVID-19. It demonstrated that at least 60% efficacy in clinical trials and preventing coronavirus disease. And in fact, the real-world evidence suggests that the effectiveness could be even higher than that.” Cooke said Further.
